SCHEMBL4120347

SCHEMBL4120347

CC(C)(CCc1ccccc1)NN

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.48
CYP2D6 P10635 3/20 0.48
LMNA P02545 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SLC6A2 P23975 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
IDO1 P14902 2/20 0.48
CYP1A2 P05177 2/20 0.48
AOC3 Q16853 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
KDM1A O60341 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10203428 0.81 LMNA (0.63) CYP3A4CYP2D6LMNANPC1RAB9A
SCHEMBL5397874 0.78 CYP2D6 (0.65) CYP3A4CYP2D6LMNANPC1RAB9A
SCHEMBL21058251 0.78 ATM (0.52) CYP3A4CYP2D6LMNANPC1RAB9A
SCHEMBL5608113 0.78 SSTR4 (0.44) CYP3A4CYP2D6LMNAIDO1SSTR4
Bromide SCHEMBL821754 0.76 SSTR4 (0.43) CYP2D6LMNANPC1RAB9AALDH1A1
Iodide SCHEMBL821553 0.76 SSTR4 (0.43) CYP2D6LMNANPC1RAB9AALDH1A1
Hydrochloric Acid SCHEMBL822005 0.76 SSTR4 (0.43) CYP2D6LMNANPC1RAB9ASSTR4
Fluoride Ion SCHEMBL822160 0.76 SSTR4 (0.43) CYP2D6LMNANPC1RAB9AALDH1A1
SCHEMBL451516 0.76 TAAR1 (0.60) CYP3A4CYP2D6LMNANPC1RAB9A
SCHEMBL21058237 0.76 TAAR1 (0.54) CYP3A4CYP2D6LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026068-A EP2 antagonists 小野药品工业株式会社 2022-02-08 CN disclosed
CN-102753538-A Sultam derivatives HOFFMANN LA ROCHE 2012-10-24 CN disclosed
EP-2064192-A2 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS Infinity Discovery, Inc. (US) 2009-06-03 EP disclosed
WO-2008024337-A2 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY DISCOVERY, INC. (US) 2008-02-28 WO disclosed